Edition:
India

People: Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

71.12USD
20 Aug 2019
Change (% chg)

$-0.63 (-0.88%)
Prev Close
$71.75
Open
$71.42
Day's High
$72.25
Day's Low
$71.10
Volume
459,311
Avg. Vol
601,645
52-wk High
$82.26
52-wk Low
$61.01

Yamada, Tadataka 

Dr. Tadataka Yamada, M.D., is Independent Director of Agilent Technologies, Inc. r. Yamada is currently a Venture Partner on the Life Sciences team of Frazier Healthcare Partners, a healthcare-focused investment firm. From June 2011 to June 2015, Dr. Yamada served as the Chief Medical and Scientific Officer of Takeda Pharmaceuticals International, Inc., a research-based global pharmaceutical company. Dr. Yamada previously served as President of the Global Health Program of the Bill & Melinda Gates Foundation from June 2006 to June 2011. From 2000 to 2006, Dr. Yamada was Chairman of Research and Development for GlaxoSmithKline Inc. and prior to that, he held research and development positions at SmithKline Beecham. Prior to joining SmithKline Beecham, Dr. Yamada was Chairman of the Department of Internal Medicine at the University of Michigan Medical School and Physician-in-Chief of the University of Michigan Medical Center.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 194,044
Long-Term Incentive Plans, USD --
All Other, USD 120,000
Fiscal Year Total, USD 314,044

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --